Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 19.67M | $ 203K | 1.03% |
3/31/2025 | $ 21.6M | $ 220K | 1.02% |
12/31/2024 | $ 9.39M | $ 272K | 2.9% |
9/30/2024 | $ 7.74M | $ 309K | 3.99% |
6/30/2024 | $ 10.04M | $ 334K | 3.33% |
3/31/2024 | $ 10.24M | $ 377K | 3.68% |
12/31/2023 | $ 11.77M | $ 390K | 3.31% |
9/30/2023 | $ 8.56M | $ 402K | 4.69% |
6/30/2023 | $ 10.45M | $ 456K | 4.37% |
3/31/2023 | $ 11.61M | $ 48K | 0.41% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for ENTERA BIO LTD is calculated as follows: Debt [ $ 216K ] / Assets [ $ 8.78M ]
(=) Debt to Assets [ 2.46% ]
Minimum
Mar 31, 2023
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 4.37K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.09% |
std | 24.49% |